Abstract:OBJECTIVE:To investigate the effect of magnetic doxorubicin liposome (MDL) in the targeting treatment of nude mice bearing colon cancer.METHODS:Human colon cancer line LoVo cells were implanted hypodermically into nude mouse. Two weeks after the mouse was killed and the tumor was taken out and cut into small pieces to be retransplanted into nude mice so as to establish an experimental model. MDL was prepared by reverse-phase evaporation method. The particle size and structure of MDL were evaluated. Eighteen nude mice with colon cancer were divided into 3 groups of 3 mice: free DOX group, MDL (-) group (no magnetic field was added to the tumor surface), and MDL (+) group (magnetic field with the strength of 4,500 G was added). DOX of the dosage of 5 mg/kg was injected through the caudal vein in these 3 groups. Then the mice were killed 30 minutes after. Fluorescence spectrophotometry was used to examine the concentrations of DOX in the tissues and plasma. Another 36 nude mice with colon cancer were divided into 6 groups of 6 mice: normal saline group (as controls), DOX group, blank liposome group, magnetic liposome group, MDL (-) group (non-magnetic alloy was implanted into the tumor), and MDL (+) group (rare earth magnet was implanted into the tumor). The body weight, longest diameter of tumor, and short diameter vertical to the longest diameter were calculated regularly. The mice were killed 11 days after. The tumors were taken out to undergo staining and light microscopy. Flow cytometry was used to examine the apoptosis of tumor cells.RESULTS:The particle size of MDL was 230 nm and the magnetic particles (Fe(3)O(4)) were evenly distributed within the liposome. The DOX concentration in tumor tissue of the MDL (+) group was remarkably higher than those of the DOX and MDL (-) groups (both P < 0.05). The DOX concentration in heart and kidney of the DOX group were higher than those of the other 2 groups, and the plasma DOX concentrations of the DOX group was significantly lower than those of the other groups (all P < 0.05). The growth speed of tumor in the MDL (+) group was significantly lower, and the tumor weight was significantly less than in other groups.CONCLUSION:Magnetic doxorubicin liposome, as a carrier of anticancer drug, has a good targeting function toward the magnetite and has a significant anticancer effect.

In Vivo Antitumor Effect of Folate Stealth Liposomes Load with Doxorubicin in HeLa229 Carcinoma Nude Mice Model

Comparison of the antitumour activity between stealth liposomal doxorubicin and regular liposomal doxorubicin

Targeting Therapy of Magnetic Doxorubicin Stealth Liposome on Human Gastric Cancer Xenografts in Nude Mice

Prevention of Metastasis in a 4T1 Murine Breast Cancer Model by Doxorubicin Carried by Folate Conjugated Ph Sensitive Polymeric Micelles.

Folate-conjugated beta-cyclodextrin-based polymeric micelles with enhanced doxorubicin antitumor efficacy.

In Vitro and in Vivo Antitumor Study of Folic Acid-Conjugated Carboxymethyl Chitosan and Phenylboronic Acid–based Nanoparticles

In vitro and in vivo antitumor effects of folate-targeted ursolic acid stealth liposome.

Folate-targeted docetaxel-lipid-based-nanosuspensions for active-targeted cancer therapy.

Folate-modified poly(2-ethyl-2-oxazoline) as hydrophilic corona in polymeric micelles for enhanced intracellular doxorubicin delivery.

Preparation and Anti-Tumor Effect in Vitro of Doxorubicin-Loaded Targeting Micelles Modified by Folic Acid

In vitro evaluation of a Folate-bovine serum albumin-doxorubicin conjugate.

Preparation and in Vitro Anti-tumor Activity Evaluation of Folate-conjugated Polymeric Micelles Loaded with Doxorubicin

In Vitro and in Vivo Evaluation of Folate Receptor-Targeting Amphiphilic Copolymer-Modified Liposomes Loaded with Docetaxel.

[Targeting Therapy of Magnetic Doxorubicin Liposome in Nude Mice Bearing Colon Cancer].

Preparation of Irinotecan-Loaded Folate-Targeted Liposome for Tumor Targeting Delivery and Its Antitumor Activity

In Vitro Cytotoxicity and Antitumor Activity of Dual-Targeting Drug Delivery System Based on Modified Magnetic Carbon by Folate

Folate and TAT Peptide Co-Modified Liposomes Exhibit Receptor-Dependent Highly Efficient Intracellular Transport of Payload in Vitro and in Vivo

Co-delivery of Doxorubicin and Bmi1 Sirna by Folate Receptor Targeted Liposomes Exhibits Enhanced Anti-Tumor Effects in Vitro and in Vivo.

Isomeric Folate-Conjugated Polymeric Micelles Bind to Folate Receptors and Display Anticancer Effects.

5-fluorouracil carrying nanoparticles with folate-targeted modification for cholangiocarcinoma: an experimental study

Doxorubicin-Loaded Micelles Based on Folic Acid Conjugated Ph-Dependent Thermo-Sensitive Copolymer: in Vitro and in Vivo Evaluation